Adriamycin in ovarian cancer patients resistant to cyclophosphamide

Eur J Cancer (1965). 1978 Dec;14(12):1401-2. doi: 10.1016/0014-2964(78)90125-1.
No abstract available

MeSH terms

  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use*
  • Drug Resistance
  • Female
  • Humans
  • Middle Aged
  • Ovarian Neoplasms / drug therapy*

Substances

  • Doxorubicin
  • Cyclophosphamide